Sign In

EMEA

Adidas catch-up remains off the necessary pace

13 Mar 2024

The $37 bln sneaker maker is emerging from its Yeezy trainer crisis. CEO Bjorn Gulden’s focus on fashionable trainers is helping to grow sales. But given the ropey economic outlook, which is hitting rival Nike, investors don’t yet look convinced he can deliver on his ambitions.

UK monarchy suffers an impairment to its goodwill

13 Mar 2024

A poorly edited photo of the Princess of Wales has fanned a firestorm of speculation about her health. If Britain’s royal family were a listed company, it would have a fiduciary duty to provide more detail. While the hit to its brand equity is not visible, it’s still tangible.

Bill Winters pulls a poor man’s Jamie Dimon

13 Mar 2024

The frontrunner to succeed StanChart's CEO has abruptly left the bank. JPMorgan's boss is adept at ousting executives, Winters included, but Dimon has earnings and investors on his side. Winters wants for the latter. The lack of a clear heir is now another worry for the board.

Capital Calls: Small Fed windows

12 Mar 2024

Concise views on global finance: US consumer prices rose 3.2% year-on-year in February, above the Federal Reserve’s 2% target, prompting traders to rein in hopes for rate cuts. The agency’s Chair Jerome Powell could have avoided that by guiding markets towards a higher number.

Generali has some scope to think bigger on M&A

12 Mar 2024

Under CEO Philippe Donnet, the $38 bln insurer did smallish deals. Targeting big players like $16 bln Aviva, to shrink a gap with rivals, may require clashing top investors to back an equity hike. But Generali could also fund a large buy by running down its chunky capital buffer.

EU’s spending snags spoil joint borrowing success

12 Mar 2024

Europe’s 800 bln euro stimulus plan is stuck. The bonds that finance it sell like hotcakes, but so far it has paid out only 225 bln euros as countries struggle with projects. Unless the bloc can show it can use the money it raises from investors, it will lose much-needed funds.

Apple’s Epic fail powers up EU tech oversight cred

11 Mar 2024

The $2.6 trln firm quickly reversed its decision to close ‘Fortnite’ maker Epic Games’ developer account. Frowns from the EU, which is going after Big Tech via fresh laws, look to have played a role. The episode is as much a victory for the bloc’s credibility as it is for Epic.

IMF’s Egypt bailout chooses hope over experience

11 Mar 2024

Cairo has received an $8 bln IMF loan after a $35 bln cash injection from the United Arab Emirates. If President Sisi does not justify the Fund’s optimism about reforms, a painful restructuring of the $165 bln external debt lies ahead.

Europe will struggle to unite if Ukraine loses

11 Mar 2024

Jean Monnet, one of the European Union’s founders, predicted it ‘will be forged in crises’. Russian success in Ukraine could be the wake-up call the bloc needs to forge closer security ties. But it could also fragment under the strain. All the more reason to ramp up support now.

Capital Calls: Packaging M&A

8 Mar 2024

Concise views on global finance: A potential 11 bln pound tie-up of UK-listed packaging companies DS Smith and Mondi will rest on yet-to-be-disclosed synergies.

Nickel rout is energy-transition warning for West

8 Mar 2024

Prices of the battery metal have halved in a year, leaving many mines unprofitable or mothballed. Indonesia’s China-backed industry now dominates. Piecemeal aid and a green premium push are unlikely to alter that. Absent smart planning, copper and lithium are vulnerable, too.

Slow growth puts ECB before Fed in rate-cut line

7 Mar 2024

The European Central Bank held borrowing costs but President Christine Lagarde suggested it might lower them in June. That could make her the first major central banker to ease policy, ahead of US Federal Reserve boss Jay Powell. Sadly, that’s only due to dire euro zone growth.

Microsoft is case study in weathering EU techlash

7 Mar 2024

The $3 trln group has taken a stake in French startup Mistral AI and kept its browser, search engine and ad sales platform clear of the European Union’s new Digital Markets Act. Things could change. But so far Microsoft shows how US firms can work around the Brussels backlash.

Virgin Money sale is UK challenger banks’ swansong

7 Mar 2024

Nationwide Building Society is paying a high premium for the embattled lender, but accounting gains and the scope to rival giants like Lloyds Banking Group sweeten the $3.7 bln deal. Still, the demise of the most prominent smaller bank suggests the sector is reverting to form.

UK ‘non-dom’ slap is right move for wrong reason

6 Mar 2024

Finance minister Jeremy Hunt scrapped tax benefits for people living in the UK but officially domiciled abroad. That improves fiscal fairness and may raise over $3 bln per year. But the benefits are uncertain and the funds went to pre-election giveaways, not public services.

L&G is an insurer with a fossil fuel-style problem

6 Mar 2024

The $18 bln UK group has underperformed European rivals. New CEO António Simões at least has a booming business in taking on corporate pension schemes. But like Shell and BP’s oil fields these are a finite resource, necessitating a durable Plan B.

Swarming investor gnats circle too widely

6 Mar 2024

New US rules have started helping smaller fund managers make a mark. They’re increasingly needling boards and stinging CEOs. When they flit around bigger targets such as Disney and Crown Castle, however, they’re easily swatted away and become a nuisance for larger activists.

Galderma IPO offers EQT a temporary facelift

6 Mar 2024

The Swiss skin care group is looking to raise $2 bln in a listing to cut debt. At $22 bln, in line with L’Oréal’s valuation, its private equity owners could get decent returns. But with the French beauty giant growing similar products faster, retaining margins may be challenging.

Bayer’s inertia will make mounting problems worse

5 Mar 2024

The $30 bln seeds and drugs maker has ruled out a rapid breakup. Bayer could have used a consumer health sale to cut debt and offset bigger US litigation costs. Betting instead that it can grow its way out of trouble risks exacerbating a yawning discount to the sum of its parts.